Search research articles
Contact Us
Filters
Showing results (251-260 of 261) with videos related to
Page
of 27
Sort By:
Science Translational Medicine
|
November 2, 2022
Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis
Yaohua Zhang, Chengcao Sun, Yajuan Li, et al.
Science Advances
|
February 1, 2023
Tumor-associated nonmyelinating Schwann cell-expressed <i>PVT1</i> promotes pancreatic cancer kynurenine pathway and tumor immune exclusion
Chengcao Sun, Youqiong Ye, Zhi Tan, et al.
Nature Communications
|
November 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
Ivan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Nature Communications
|
January 10, 2018
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
Ivan Vannini, Petra M Wise, Kishore B Challagundla, et al.
The Journal of Clinical Investigation
|
February 27, 2018
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
Na Zhao, Jin Cao, Longyong Xu, et al.
Science (New York, N.Y.)
|
August 6, 2021
A noncoding RNA modulator potentiates phenylalanine metabolism in mice
Yajuan Li, Zhi Tan, Yaohua Zhang, et al.
Nature Immunology
|
June 5, 2019
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
Qingsong Hu, Youqiong Ye, Li-Chuan Chan, et al.
Molecular Cell
|
September 22, 2017
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2
Roxana S Redis, Luz E Vela, Weiqin Lu, et al.
Molecular Cell
|
February 9, 2016
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2
Roxana S Redis, Luz E Vela, Weiqin Lu, et al.
European Heart Journal
|
June 27, 2020
Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial
Jun-Jie Zhang, Fei Ye, Kai Xu, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 261) with videos related to
Sort By:
Page
of 27
Science Translational Medicine
|
November 2, 2022
Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis
Yaohua Zhang, Chengcao Sun, Yajuan Li, et al.
Science Advances
|
February 1, 2023
Tumor-associated nonmyelinating Schwann cell-expressed <i>PVT1</i> promotes pancreatic cancer kynurenine pathway and tumor immune exclusion
Chengcao Sun, Youqiong Ye, Zhi Tan, et al.
Nature Communications
|
November 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
Ivan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Nature Communications
|
January 10, 2018
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
Ivan Vannini, Petra M Wise, Kishore B Challagundla, et al.
The Journal of Clinical Investigation
|
February 27, 2018
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
Na Zhao, Jin Cao, Longyong Xu, et al.
Science (New York, N.Y.)
|
August 6, 2021
A noncoding RNA modulator potentiates phenylalanine metabolism in mice
Yajuan Li, Zhi Tan, Yaohua Zhang, et al.
Nature Immunology
|
June 5, 2019
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
Qingsong Hu, Youqiong Ye, Li-Chuan Chan, et al.
Molecular Cell
|
September 22, 2017
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2
Roxana S Redis, Luz E Vela, Weiqin Lu, et al.
Molecular Cell
|
February 9, 2016
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2
Roxana S Redis, Luz E Vela, Weiqin Lu, et al.
European Heart Journal
|
June 27, 2020
Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial
Jun-Jie Zhang, Fei Ye, Kai Xu, et al.
Page
of 27